Will a peripheral blood (PB) sample yield the same diagnostic and prognostic cytogenetic data as the concomitant bone marrow (BM) in myelodysplasia?-Reference-Cited by-同舟云学术

Will a peripheral blood (PB) sample yield the same diagnostic and prognostic cytogenetic data as the concomitant bone marrow (BM) in myelodysplasia?

Published:2012-07 Issue:7 Volume:36 Page:832-840
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Cherry Athena M.,Slovak Marilyn L.,Campbell Lynda J.,Chun Kathy,Eclache Virginie,Haase Detlef,Haferlach Claudia,Hildebrandt Barbara,Iqbal Anwar M.,Jhanwar Suresh C.,Ohyashiki Kazuma,Sole Francesc,Vandenberghe Peter,VanDyke Daniel L.,Zhang Yanming,Dewald Gordon W.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference24 articles.

1. The world health organization (WHO) classification of the myeloid neoplasma;Vardiman;Blood,2002

2. World Health Organization of Tumors. Pathology and genetics of tumors of haematopoietic and lymphoid tissues;Jaffe,2001

3. Hematologic and cytogenetic response to lenalidomide in myelodysplastic syndrome with chromosome 5q deletion;List;N Eng J Med,2006

4. Cytogenetic studies in 174 consecutive patients with preleukemic or myelodysplastic syndromes;Knapp;Mayo Clin Proc,1985

5. Problematic WHO reclassification of myelodysplastic syndromes;Greenberg;J Clin Oncol,2000

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Section E6.1–6.6 of the American College of Medical Genetics and Genomics (ACMG) Technical Laboratory Standards: Cytogenomic studies of acquired chromosomal abnormalities in neoplastic blood, bone marrow, and lymph nodes;Genetics in Medicine;2024-04

2. Myelodysplastic Syndrome;Comprehensive Hematology and Stem Cell Research;2024

3. Myeloid NGS Analyses of Paired Samples from Bone Marrow and Peripheral Blood Yield Concordant Results: A Prospective Cohort Analysis of the AGMT Study Group;Cancers;2023-04-14

4. Molecular and cytogenetic characterization of myelodysplastic syndromes in cell-free DNA;Blood Advances;2022-05-23

5. European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms;Leukemia;2019-01-29